FindTrial
Sign In

To compare two diffferent doses of prophylactic intravenous administration of Magnesium sulphate for prevention of shivering in patients undergoing procedures under spinal anaesthesia.

Comparison of two different doses of prophylactic intravenous administration of Magnesium sulphate for prevention of shivering in patients undergoing spinal anaesthesia. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/06/089023
Enrollment
88
Registered
2025-06-18
Start date
Unknown
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Injection Magnesium sulphate 25mg/kg IV : Prospectively for the six months duration, patient undergoing procedures under spinal anaesthesia will be randomly taken as group A and group B

Sponsors

Sree Balaji medical college and hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA I AND II

Exclusion criteria

Exclusion criteria: ASA III AND ABOVE ALLERGIC REACTIONS PATIENT NOT WILLING BLEEDING DISORDER PREGNANCY

Design outcomes

Primary

MeasureTime frame
To compare the abolition of shivering caused during perioperative and post operative period for patients undergoing procedures under spinal anaesthesiaTimepoint: Abolition of shivering within 1 hour after administration of Injection Magnesium sulphate intravenously—

Secondary

MeasureTime frame
nilTimepoint: nil—

Countries

India

Contacts

Public ContactBotta bhagyavardhan

Bharath institute of higher education and research

Bhagyavardhan@gmail.com9894468502

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026